Details for 2017814267

Up to date per 04.04.2026

Actions

Title / Product Name

HERSTELLUNG VON FAKTOR-XA-DERIVATEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017814267

EP Publication Number

3472314

E-Number

1389865

Language

PCT Number

US17038169

Publication Date

24.04.2019 A

05.05.2021 B1

Registration Date

05.05.2021

AT Publication Date

15.05.2021

Application Date

19.06.2017

Registration Number

Priorities

17.06.2016

201662351841 P

IPC

C12N 9/64 20060101AFI20191213BHEP

Maximum Duration of Protection

19.06.2037

Owner

Alexion Pharmaceuticals, Inc.121 Seaport Boulevard Boston, MA 02210US

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT

Inventor

KARBARZ, Markc/o Portola Pharmaceuticals Inc. 270 E. Grand Ave. Suite 22 South San Francisco, California 94080US

CONLEY, Pamela B.c/o Portola Pharmaceuticals Inc. 270 E. Grand Ave. Suite 22 South San Francisco, California 94080US

LU, Genminc/o Portola Pharmaceuticals Inc. 270 E. Grand Ave. Suite 22 South San Francisco, California 94080US

Information about Fees